A national university located in Osaka, Japan, and founded in 1931, with roots going back as far as 1838 and the establishment of the private "place of learning," Tekijuku, Osaka University is a premier research university not only in Japan but globally as well. With 11 undergraduate schools, 15 graduate schools, two university hospitals, as well as a number of research institutes and joint-use facilities (including the World Premier International Research Center Initiative's Immunology Frontier Research Center) spread over 3 campuses, Osaka University is well-equipped to meet the research needs of the modern era. Osaka University is also home to over 15,000 undergraduate and nearly 8,000 graduate students, of which over 2,000 are from overseas, emphasizing the university's commitment to developing world leaders for this generation and generations to come.
解鎖市場時間軸與訊號動態
此公司進入各市場的次序 — 由最舊至最新
註冊以查看完整訊號動態
Osaka University 的國際擴張與競爭對手的比較
Osaka University你長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
 Osaka University你 | 0 | 0 | 0% | 0 | 60 |
目前並無招聘
註冊以追蹤此公司，並在發生變化時第一時間獲得提醒。
無進行中的廣告活動
註冊以追蹤此公司，並在發生變化時第一時間獲得提醒。
Telix製藥在日本橫濱開設Telix製造解決方案，這是其在亞太地區的首個迴旋加速器設施，提高了日本患者獲得放射性藥物的機會。
Alpha Fusion 開始 af-001 的第一期臨床試驗，這是一種用於分化型甲狀腺癌的α發射放射性藥物，旨在提供門診治療選擇。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 Osaka University 業務、市場及增長訊號的快速解答。
